Purpose: The purpose of this study is to evaluate the impact of circulating miR-126 on left ventricular remodeling and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Study Type
OBSERVATIONAL
Enrollment
1,200
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Affiliated Hospital of Binzhou Medical Universty
Binzhou, Shandong, China
Change in LVEDV from baseline by 3D-echocardiogram
The primary outcome of this study will be the change from baseline in left ventricular end diastolic volume (LVEDV) at 6 months post-PCI by 3D-echocardiogram.
Time frame: 6 months
Major adverse cardiovascular events (MACE)
Cardiovascular death, myocardial infarction, target vessel revascularization,recurrent ischaemia, heart failure
Time frame: 6 months
All cause mortality
Time frame: 6 months
Stent thrombosis
Time frame: 6 months
Change in LVESV from baseline
Change from baseline in left ventricular end systolic volume (LVESV), ejection fraction (LVEF) and mass at 6 months post-PCI by 3D-echocardiogram
Time frame: 6 months
NT-proBNP levels
Time frame: at 1 and 180 days post-PCI
Incidence of complete ST-segment resolution
Time frame: 3 hours after PCI
Peak troponin T level
Time frame: 24 hours after PCI
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Heze Municipal Hospital
Heze, Shandong, China
Qianfoshan Hospital, Shandong University
Jinan, Shandong, China
Qilu Hospital, Shandong University
Jinan, Shandong, China
Jinan Central Hospital, Shandong University
Jinan, Shandong, China
Shandong Provincial Hospital, Shandong University
Jinan, Shandong, China
Shandong Provincial Medical Imaging Institute, Shandong University
Jinan, Shandong, China
The Second Hospital of Shandong University
Jinan, Shandong, China
Jining Hospital of Traditional Chinese Medicine
Jining, Shandong, China
...and 7 more locations